share_log

啓明醫療-B:2024年第二次臨時股東大會通告

VENUS MEDTECH-B: NOTICE OF 2024 SECOND EXTRAORDINARY GENERAL MEETING

HKEX ·  Nov 19, 2024 16:56

Summary by Moomoo AI

啟明醫療-B(股份代號:2500)將於2024年12月5日上午10時在中國杭州召開2024年第二次臨時股東大會。會議將審議包括選舉古軍華先生為獨立非執行董事在內的數項普通決議案,以及特別決議案,如修訂公司章程及授予董事會發行股份的一般性授權。股東大會通告及相關決議案詳情已於2024年11月19日的通函中公布。股份過戶登記將於2024年12月2日至5日暫停,並規定股東出席大會的登記及代理人委任手續。股東大會預計將需時半日,並要求出席者自理交通及食宿費用。
啟明醫療-B(股份代號:2500)將於2024年12月5日上午10時在中國杭州召開2024年第二次臨時股東大會。會議將審議包括選舉古軍華先生為獨立非執行董事在內的數項普通決議案,以及特別決議案,如修訂公司章程及授予董事會發行股份的一般性授權。股東大會通告及相關決議案詳情已於2024年11月19日的通函中公布。股份過戶登記將於2024年12月2日至5日暫停,並規定股東出席大會的登記及代理人委任手續。股東大會預計將需時半日,並要求出席者自理交通及食宿費用。
Qiiming Medical -B (Stock Code: 2500) will hold its 2024 second extraordinary general meeting of shareholders in Hangzhou, China on December 5, 2024 at 10:00 am. The meeting will consider several ordinary resolutions, including electing Mr. Gu Junhua as an independent non-executive director, and special resolutions such as amending the company's articles of association and granting the board of directors general authorization to issue shares. Details of the shareholders' meeting notice and related resolutions have been announced in the letter dated November 19, 2024. Share transfer registration will be suspended from December 2 to 5, 2024, stipulating the registration of shareholders attending the meeting and the appointment of proxies. The shareholders' meeting is expected to last half a day and attendees are required to arrange their own transportation and accommodation expenses.
Qiiming Medical -B (Stock Code: 2500) will hold its 2024 second extraordinary general meeting of shareholders in Hangzhou, China on December 5, 2024 at 10:00 am. The meeting will consider several ordinary resolutions, including electing Mr. Gu Junhua as an independent non-executive director, and special resolutions such as amending the company's articles of association and granting the board of directors general authorization to issue shares. Details of the shareholders' meeting notice and related resolutions have been announced in the letter dated November 19, 2024. Share transfer registration will be suspended from December 2 to 5, 2024, stipulating the registration of shareholders attending the meeting and the appointment of proxies. The shareholders' meeting is expected to last half a day and attendees are required to arrange their own transportation and accommodation expenses.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more